Saltar al contenido
República del Perú · Observatorio de la producción científica universitaria
OApol.org Observatorio de Inteligencia Científica Universitaria del Perú
OApol.org
Inicio Universidades Publicaciones Investigadores
Repositorios
Tesis y trabajos académicosRevistas
Indicadores
Ranking trimestralRanking por carreraObjetivos de Desarrollo SostenibleReporte OCDERed neuronal 3D
Acerca
MetodologíaPrivacidad

Recent HIV infection and annualized HIV incidence rates among sexual and gender minorities in Brazil and Peru (ImPrEP seroincidence study): a cross-sectional, multicenter study

Torres T.S.; Teixeira S.L.M.; Hoagland B.; Konda K.A.; Derrico M.; Moreira R.I.; Guanira J.V.; Benedetti M.; Nazer S.; Calvo G.M.; Vargas S.; Benites C.; Bigolin Á.; Alonso Neto J.B.; Farias A.; Guimarães Lacerda M.V.; Raenck Silva D.A.; Paz L.C.; Madruga J.V.; Salvatierra Flores H.J.; Boluarte G.P.; Osco Tamayo C.V.; Castro Antezana H.T.; Pimenta M.C.; Bórquez A.; Luz P.M.; Grinsztejn B.; Szwarcwald C.L.; Cáceres C.F.; Veloso V.G.; Kristic T.; Rocha C.; da Silva Santos W.; Lovreto Santana A.P.; Lima R.; Souza C.; Oliva T.A.; Valões M.D.S.; Olivetto J.; Mota G.L.; Cano A.B.; Trefiglio R.; Coutinho C.; Elorreaga O.; Gutierrez X.; Olivos F.; Caviedes D.; Adriazola D.; Juárez E.; Mariño G.; Qquellon J.; Vasquez F.; Jiron J.P.; Flores S.; Campos K.; Eguiluz M. · The Lancet Regional Health - Americas (2023) · DOI: 10.1016/j.lana.2023.100642

Resumen

Background: HIV incidence estimation is critical for monitoring the HIV epidemic dynamics and the effectiveness of public health prevention interventions. We aimed to identify sexual and gender minorities (SGM) with recent HIV infections, factors associated with recent HIV infection, and to estimate annualised HIV incidence rates. Methods: Cross-sectional multicentre study in HIV testing services in Brazil and Peru (15 cities). Inclusion criteria: 18+ years, SGM assigned male at birth, not using pre-/post-exposure prophylaxis. We identified recent HIV infection using the Maxim HIV-1 LAg-Avidity EIA assay as part of a recent infection testing algorithm (RITA). Annualized HIV incidence was calculated using the UNAIDS/WHO incidence estimator tool. Multivariable logistic regression models were used to estimate factors associated with recent HIV infection. Trial registration: NCT05674682. Findings: From 31-Jan-2021 to 29-May-2022, 6899 individuals participated [Brazil: 4586 (66.5%); Peru: 2313 (33.5%)]; 5946 (86.2%) cisgender men, 751 (10.9%) transgender women and 202 (2.9%) non-binary/gender diverse. Median age was 27 (IQR: 23–34) years. HIV prevalence was 11.4% (N = 784/6899); 137 (2.0%) SGM were identified with recent HIV infection. The overall annualized HIV incidence rate was 3.88% (95% CI: 2.86–4.87); Brazil: 2.62% (95% CI: 1.78–3.43); Peru: 6.69% (95% CI: 4.62–8.69). Participants aged 18–24 years had higher odds of recent HIV infection compared to those aged 30+ years in both countries. Interpretation: Our results highlight the significant burden of HIV epidemic among SGM in large urban centres of Brazil and Peru. Public health policies and interventions to increase access to effective HIV prevention methods such as PrEP are urgently needed in Latin America. Funding: Unitaid, WHO ( Switzerland), Ministry of Health from Brazil and Peru.

Instituciones: Universidad Peruana Cayetano Heredia